Gliomatosis cerebri other imaging findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(36 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Gliomatosis cerebri}}
{{Gliomatosis cerebri}}
{{CMG}}
{{CMG}}{{AE}}{{SR}}


==Overview==
==Overview==
Other imaging studies for high-grade gliomas include [[In vivo magnetic resonance spectroscopy|MR spectroscopy]], [[perfusion weighted imaging|MR perfusion]], [[PET scan]] (markedly decreased accumulation of [18F]-fluorodeoxyglucose), and [[bone scan]] (metastasis to bones).<ref name=aaa>Radiographic features of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri</ref>
Other imaging studies for gliomatosis cerebri include [[In vivo magnetic resonance spectroscopy|MR spectroscopy]] (decreased [[N-Acetylaspartic acid|N-Acetylaspartic acid (NAA)]]/[[creatine]] ratio and elevated [[choline]]/[[creatine]] ratio, [[choline]]/[[N-Acetylaspartic acid|NAA]] ratio, and [[myo-inositol|myoinositol]]), [[perfusion weighted imaging|MR perfusion]] (low/normal relative cerebral blood flow), [[PET scan]] (markedly decreased accumulation of [[Florbetapir (18F)|[18F]-fluorodeoxyglucose]] on [[PET|F-18 FDG PET]], [[hypermetabolism]] on [[PET|C-11 methionine PET]], and marked increase in cerebral blood flow on [[PET|15(O)-water PET]]), and [[bone scan]] (metastasis to [[bones]]).


==Other Imaging Findings==
==Other Imaging Findings==
Other imaging studies for gliomatosis cerebri include [[In vivo magnetic resonance spectroscopy|MR spectroscopy]], [[perfusion weighted imaging|MR perfusion]], [[PET scan]] (markedly decreased accumulation of [18F]-fluorodeoxyglucose), and [[bone scan]] (metastasis to bones).<ref name=aaa>Radiographic features of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri</ref>
Other imaging studies for gliomatosis cerebri include:<ref name="aaa">Radiographic features of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri</ref><ref name="pmid22740882">{{cite journal| author=Rajz GG, Nass D, Talianski E, Pfeffer R, Spiegelmann R, Cohen ZR| title=Presentation patterns and outcome of gliomatosis cerebri. | journal=Oncol Lett | year= 2012 | volume= 3 | issue= 1 | pages= 209-213 | pmid=22740882 | doi=10.3892/ol.2011.445 | pmc=PMC3362440 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22740882  }} </ref><ref name="pmid20334921">{{cite journal| author=Desclée P, Rommel D, Hernalsteen D, Godfraind C, de Coene B, Cosnard G| title=Gliomatosis cerebri, imaging findings of 12 cases. | journal=J Neuroradiol | year= 2010 | volume= 37 | issue= 3 | pages= 148-58 | pmid=20334921 | doi=10.1016/j.neurad.2009.12.001 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20334921  }} </ref>


===1. MR Spectroscopy===
===1. Magnetic Resonance Spectroscopy===
Other imaging studies for gliomatosis cerebri include [[In vivo magnetic resonance spectroscopy|MR spectroscopy]]. Common findings are described below:<ref name=aaa>Radiographic features of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri</ref>
[[In vivo magnetic resonance spectroscopy|MR spectroscopy]] may be helpful in the diagnosis of gliomatosis cerebri. Findings on [[In vivo magnetic resonance spectroscopy|MR spectroscopy]] suggestive of gliomatosis cerebri include:<ref name="aaa">Radiographic features of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri</ref><ref name="pmid20334921">{{cite journal| author=Desclée P, Rommel D, Hernalsteen D, Godfraind C, de Coene B, Cosnard G| title=Gliomatosis cerebri, imaging findings of 12 cases. | journal=J Neuroradiol | year= 2010 | volume= 37 | issue= 3 | pages= 148-58 | pmid=20334921 | doi=10.1016/j.neurad.2009.12.001 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20334921  }} </ref>
*Decreased [[N-Acetylaspartic acid|N-Acetylaspartic acid (NAA)]]/[[creatine]] ratio
*Elevated [[choline]]/[[creatine]] ratio
*Elevated [[choline]]/[[creatine]] ratio
*Elevated [[choline]]/[[N-Acetylaspartic acid|NAA]] ratio
*Elevated [[choline]]/[[N-Acetylaspartic acid|NAA]] ratio
*Marked elevation of [[myo-inositol|myoinositol]]
*Elevated [[myo-inositol|myoinositol]]


===2. MR Perfusion===
===2. Magnetic Resonance Perfusion===
Other imaging studies for gliomatosis cerebri include [[perfusion weighted imaging|MR perfusion]]. Common findings are described below:<ref name=aaa>Radiographic features of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri</ref>
[[perfusion weighted imaging|MR perfusion]] may be helpful in the diagnosis of gliomatosis cerebri. Findings on [[perfusion weighted imaging|MR perfusion]] suggestive of gliomatosis cerebri include:<ref name="aaa">Radiographic features of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri</ref>
*​Low/normal relative cerebral blood flow (no vascular [[hyperplasia]])
*​Low/normal relative cerebral blood flow (no vascular [[hyperplasia]])


===3. PET===
===3. Positron Emission Tomography===
Other imaging studies for high-grade gliomas include [[PET scan]], which demonstrates markedly decreased accumulation of [18F]-fluorodeoxyglucose ([[glucose metabolism|glucose hypometabolism]]).<ref name=aaa>Radiographic features of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri</ref>
[[PET scan]] may be helpful in the diagnosis of gliomatosis cerebri. Findings on [[PET scan]] suggestive of gliomatosis cerebri include:<ref name="aaa">Radiographic features of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri</ref><ref name="pmid22740882">{{cite journal| author=Rajz GG, Nass D, Talianski E, Pfeffer R, Spiegelmann R, Cohen ZR| title=Presentation patterns and outcome of gliomatosis cerebri. | journal=Oncol Lett | year= 2012 | volume= 3 | issue= 1 | pages= 209-213 | pmid=22740882 | doi=10.3892/ol.2011.445 | pmc=PMC3362440 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22740882  }} </ref>
*[[PET|F-18 FDG PET]] images show markedly decreased accumulation of [[Florbetapir (18F)|[18F]-fluorodeoxyglucose]] ([[glucose metabolism|glucose hypometabolism]]).
*[[PET|C-11 methionine PET]] images show [[hypermetabolism]].
*[[PET|15(O)-water PET]] images show a marked increase in cerebral blood flow in gliomatosis cerebri lesions.


===4. Bone Scan===
===4. Bone Scan===
[[Bone scan]] may be performed to detect metastases of gliomatosis cerebri to bones.
*Most malignant gliomas get metastasized to the bones via the hematogenous spread.<ref name="pmid24212625">{{cite journal| author=Beauchesne P| title=Extra-neural metastases of malignant gliomas: myth or reality? | journal=Cancers (Basel) | year= 2011 | volume= 3 | issue= 1 | pages= 461-77 | pmid=24212625 | doi=10.3390/cancers3010461 | pmc=PMC3756372 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24212625  }} </ref>
*[[Bone scan]] may be performed to detect metastases of gliomatosis cerebri to [[bones]].


==References==
==References==
Line 36: Line 41:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Neurology]]
[[Category:Neurosurgery]]

Latest revision as of 16:42, 7 October 2019

Gliomatosis cerebri Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gliomatosis cerebri from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gliomatosis cerebri other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gliomatosis cerebri other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gliomatosis cerebri other imaging findings

CDC on Gliomatosis cerebri other imaging findings

Gliomatosis cerebri other imaging findings in the news

Blogs on Gliomatosis cerebri other imaging findings

Directions to Hospitals Treating Gliomatosis cerebri

Risk calculators and risk factors for Gliomatosis cerebri other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Other imaging studies for gliomatosis cerebri include MR spectroscopy (decreased N-Acetylaspartic acid (NAA)/creatine ratio and elevated choline/creatine ratio, choline/NAA ratio, and myoinositol), MR perfusion (low/normal relative cerebral blood flow), PET scan (markedly decreased accumulation of [18F]-fluorodeoxyglucose on F-18 FDG PET, hypermetabolism on C-11 methionine PET, and marked increase in cerebral blood flow on 15(O)-water PET), and bone scan (metastasis to bones).

Other Imaging Findings

Other imaging studies for gliomatosis cerebri include:[1][2][3]

1. Magnetic Resonance Spectroscopy

MR spectroscopy may be helpful in the diagnosis of gliomatosis cerebri. Findings on MR spectroscopy suggestive of gliomatosis cerebri include:[1][3]

2. Magnetic Resonance Perfusion

MR perfusion may be helpful in the diagnosis of gliomatosis cerebri. Findings on MR perfusion suggestive of gliomatosis cerebri include:[1]

  • ​Low/normal relative cerebral blood flow (no vascular hyperplasia)

3. Positron Emission Tomography

PET scan may be helpful in the diagnosis of gliomatosis cerebri. Findings on PET scan suggestive of gliomatosis cerebri include:[1][2]

4. Bone Scan

  • Most malignant gliomas get metastasized to the bones via the hematogenous spread.[4]
  • Bone scan may be performed to detect metastases of gliomatosis cerebri to bones.

References

  1. 1.0 1.1 1.2 1.3 Radiographic features of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri
  2. 2.0 2.1 Rajz GG, Nass D, Talianski E, Pfeffer R, Spiegelmann R, Cohen ZR (2012). "Presentation patterns and outcome of gliomatosis cerebri". Oncol Lett. 3 (1): 209–213. doi:10.3892/ol.2011.445. PMC 3362440. PMID 22740882.
  3. 3.0 3.1 Desclée P, Rommel D, Hernalsteen D, Godfraind C, de Coene B, Cosnard G (2010). "Gliomatosis cerebri, imaging findings of 12 cases". J Neuroradiol. 37 (3): 148–58. doi:10.1016/j.neurad.2009.12.001. PMID 20334921.
  4. Beauchesne P (2011). "Extra-neural metastases of malignant gliomas: myth or reality?". Cancers (Basel). 3 (1): 461–77. doi:10.3390/cancers3010461. PMC 3756372. PMID 24212625.


Template:WikiDoc Sources